619 related articles for article (PubMed ID: 12957806)
1. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
2. Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
Yarandi F; Izadi Mood N; Mirashrafi F; Eftekhar Z
Aust N Z J Obstet Gynaecol; 2004 Dec; 44(6):514-6. PubMed ID: 15598287
[TBL] [Abstract][Full Text] [Related]
3. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
Alanen KW; Elit LM; Molinaro PA; McLachlin CM
Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
[TBL] [Abstract][Full Text] [Related]
5. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
[TBL] [Abstract][Full Text] [Related]
6. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
Pretorius RG; Belinson JL; Zhang WH; Burchette RJ; Elson P; Qiao YL
J Reprod Med; 2001 Aug; 46(8):724-8. PubMed ID: 11547646
[TBL] [Abstract][Full Text] [Related]
7. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?
Sherman ME; Kelly D
Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women.
Chhieng DC; Elgert P; Cohen JM; Cangiarella JF
Cancer; 2001 Feb; 93(1):1-7. PubMed ID: 11241259
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of women with atypical squamous cells of undetermined significance (ASCUS).
Emerson RE; Puzanov A; Brunnemer C; Younger C; Cramer H
Diagn Cytopathol; 2002 Sep; 27(3):153-7. PubMed ID: 12203862
[TBL] [Abstract][Full Text] [Related]
10. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
11. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
12. [Suspicious findings in gynecologic cytodiagnosis].
Koroschetz F
Wien Klin Wochenschr; 1991; 103(12):357-61. PubMed ID: 1926863
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and management of the AGUS Papanicolaou smear.
Kaferle JE; Malouin JM
Am Fam Physician; 2001 Jun; 63(11):2239-44. PubMed ID: 11417776
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
16. Atypical squamous cells of undetermined significance qualified: a follow-up study.
Kline MJ; Davey DD
Diagn Cytopathol; 1996 Jun; 14(4):380-4. PubMed ID: 8725142
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for the management of women with abnormal cervical smears 1998.
Jones RW; Best DV; Cox B; Fitzgerald NW; Hill M; Jennings P; Peddie D; Sage MJ
N Z Med J; 2000 May; 113(1109):168-71. PubMed ID: 10894344
[TBL] [Abstract][Full Text] [Related]
18. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia.
Elhakeem HA; Al-Ghamdi AS; Al-Maghrabi JA
Saudi Med J; 2005 Apr; 26(4):588-92. PubMed ID: 15900366
[TBL] [Abstract][Full Text] [Related]
19. Importance of atypical glandular cells of uncertain significance in cervical cytologic smears.
Korn AP; Judson PL; Zaloudek CJ
J Reprod Med; 1998 Sep; 43(9):774-8. PubMed ID: 9777615
[TBL] [Abstract][Full Text] [Related]
20. Atypical reparative change on cervical/vaginal smears may be associated with dysplasia.
Rimm DL; Gmitro S; Frable WJ
Diagn Cytopathol; 1996 Jun; 14(4):374-9. PubMed ID: 8725141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
